Conference
ROSIGLITAZONE-BASED THERAPY REDUCES INFLAMMATORY BIOMARKERS IN DIABETIC, HYPERTENSIVE PATIENTS COMPARED TO A METFORMIN AND GLYBURIDE BASED-REGIMEN: THE ROSITEL RANDOMIZED TRIAL
Authors
Gupta M; Teoh H; Kajil M; Tsigoulis M; Quan A; Braga M; Verma S
Volume
26
Pagination
pp. 125D-125D
Publisher
PULSUS GROUP INC
Publication Date
October 1, 2010
Conference proceedings
CANADIAN JOURNAL OF CARDIOLOGY
ISSN
0828-282X